Among all the receptors in this family, LDLR and LRP1 are well‐known to be overexpressed in GBM tissues as compared to normal brain tissues [8, 9], suggesting their potential key role in regulating tumor aggressiveness and malignant potential, and thus in tumor progression. This evidence concerns the gene LDLR and glioblastoma.